Sleep disturbances are common among individuals with leukemia, and they can significantly impact their overall well-being. Acupuncture and foot reflexology, two alternative therapies rooted in traditional Chinese medicine, have gained recognition for their potential to address sleep issues and alleviate associated symptoms. This single blinded, three-groups randomized controlled trial was navigated at Tohid Hospital, involving 132 leukemia patients divided into acupuncture (n = 44), foot reflexology (n = 44), and control (n = 44) groups via random card selection. All patients completed a demographic questionnaire and the Pittsburgh Sleep Quality Index (PSQI) before the intervention. The acupuncture group received routine care along with twice-daily acupuncture at the SP6 point for four successive weeks. Reflexology group had daily ten-minute sittings for the same weeks using sweet almond oil on their feet. Control group continued by only routine cares. Post-intervention assessments were conducted using the same instruments after four weeks. The study analyzed patient demographics, finding no significant gender differences and a majority of high school graduates. All groups had similar proportions of singles, high employment rates, and urban residency. Average ages were comparable, with no significant pre-intervention sleep quality differences found. However, both acupuncture and reflexology groups showed significant improvements post-intervention, unlike the control group. While both interventions resulted in lower sleep quality scores compared to the control, no significant difference was observed between the acupuncture and reflexology groups. Trends indicated slight reductions in fatigue for the intervention groups, suggesting both therapies effectively improved sleep quality. Acupuncture and foot reflexology are suggested as simple and budget-friendly complementary methods that may improve sleep quality for those with leukemia. These therapies provide non-invasive methods to address sleep disturbances and improve overall well-being in leukemia patients.
Read full abstract